Your Honest Care Report summarizes your diet and exercise history, your past weight loss attempts, weight loss medications you previously tried, and any unique challenges you face that make a GLP-1 medically necessary
doi: 10.3390/jcm14134619
Research goals: Metabolic & Weight Description Retatrutide (development code LY3437943) is a synthetic, once-weekly triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors that has been the subject of peer-reviewed phase 1 and phase 2 randomized controlled trials published in The New England Journal of Medicine , The Lancet , and Nature Medicine , including investigations of body weight, glycemic control, and hepatic steatosis in adult human participants
A restorative antioxidant infusion that supports detoxification, reduces oxidative stress, and promotes a brighter, more even skin tone from within
Customization Service Product specifications can be customized to create your own peptide brand